Soluble TWEAK plasma levels increase after renal transplantation and associate with the improvement of endothelial function. (20th September 2013)
- Record Type:
- Journal Article
- Title:
- Soluble TWEAK plasma levels increase after renal transplantation and associate with the improvement of endothelial function. (20th September 2013)
- Main Title:
- Soluble TWEAK plasma levels increase after renal transplantation and associate with the improvement of endothelial function
- Authors:
- Yilmaz, Mahmut I.
Sonmez, Alper
Saglam, Mutlu
Yaman, Halil
Unal, Hilmi Umut
Gok, Mahmut
Cetinkaya, Hakki
Eyileten, Tayfun
Oguz, Yusuf
Sari, Sebahattin
Yildirim, Ali Osman
Vural, Abdulgaffar
Carrero, Juan J.
Blanco‐Colio, Luis M. - Abstract:
- <abstract abstract-type="main" id="eci12166-abs-0001"> <title>Abstract</title> <sec id="eci12166-sec-0001" sec-type="section"> <title>Background</title> <p>Soluble TWEAK (sTWEAK) and asymmetric dimethyl arginine (ADMA) concentrations have been associated with endothelial function in patients with chronic kidney disease (CKD). We tested the hypothesis that the improvement in endothelial function observed after renal transplantation is directly linked to the normalization of both sTWEAK and ADMA.</p> </sec> <sec id="eci12166-sec-0002" sec-type="section"> <title>Materials and methods</title> <p>One hundred and seventy‐five kidney transplant recipients (71% men; 31·6 ± 9·4 years) were studied immediately before and on the 180th day post‐transplantation. At each visit, blood samples were taken to assess circulating levels of sTWEAK and ADMA. Brachial artery endothelium‐dependent vasodilatation (FMD) assessments were also performed.</p> </sec> <sec id="eci12166-sec-0003" sec-type="section"> <title>Results</title> <p>Renal transplantation was followed by an improvement in FMD. This improvement was paralleled by an increase in sTWEAK and a reduction in ADMA after transplantation (<italic>P</italic> &lt; 0·001 for all). Cross‐sectionally, both molecules associated with FMD before as well as after transplantation (<italic>P</italic> &lt; 0·001 for all). Longitudinally, the changes observed in sTWEAK (β = 0·26, <italic>P</italic> &lt; 0·001) and ADMA (β = −0·44,<abstract abstract-type="main" id="eci12166-abs-0001"> <title>Abstract</title> <sec id="eci12166-sec-0001" sec-type="section"> <title>Background</title> <p>Soluble TWEAK (sTWEAK) and asymmetric dimethyl arginine (ADMA) concentrations have been associated with endothelial function in patients with chronic kidney disease (CKD). We tested the hypothesis that the improvement in endothelial function observed after renal transplantation is directly linked to the normalization of both sTWEAK and ADMA.</p> </sec> <sec id="eci12166-sec-0002" sec-type="section"> <title>Materials and methods</title> <p>One hundred and seventy‐five kidney transplant recipients (71% men; 31·6 ± 9·4 years) were studied immediately before and on the 180th day post‐transplantation. At each visit, blood samples were taken to assess circulating levels of sTWEAK and ADMA. Brachial artery endothelium‐dependent vasodilatation (FMD) assessments were also performed.</p> </sec> <sec id="eci12166-sec-0003" sec-type="section"> <title>Results</title> <p>Renal transplantation was followed by an improvement in FMD. This improvement was paralleled by an increase in sTWEAK and a reduction in ADMA after transplantation (<italic>P</italic> &lt; 0·001 for all). Cross‐sectionally, both molecules associated with FMD before as well as after transplantation (<italic>P</italic> &lt; 0·001 for all). Longitudinally, the changes observed in sTWEAK (β = 0·26, <italic>P</italic> &lt; 0·001) and ADMA (β = −0·44, <italic>P</italic> &lt; 0·001) levels were independently associated with the improvement of FMD (<italic>r</italic><sup>2</sup> = 0·30).</p> </sec> <sec id="eci12166-sec-0004" sec-type="section"> <title>Conclusions</title> <p>Renal transplantation is followed by an improvement of FMD that is independently associated with the normalization of both sTWEAK and ADMA concentrations. We identify two surrogate biomarkers of endothelial function with potential as therapeutic targets.</p> </sec> </abstract> … (more)
- Is Part Of:
- European journal of clinical investigation. Volume 43:Number 12(2013:Dec.)
- Journal:
- European journal of clinical investigation
- Issue:
- Volume 43:Number 12(2013:Dec.)
- Issue Display:
- Volume 43, Issue 12 (2013)
- Year:
- 2013
- Volume:
- 43
- Issue:
- 12
- Issue Sort Value:
- 2013-0043-0012-0000
- Page Start:
- 1250
- Page End:
- 1257
- Publication Date:
- 2013-09-20
- Subjects:
- Pathology -- Periodicals
Medical research -- Periodicals
616.075 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2362 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/eci.12166 ↗
- Languages:
- English
- ISSNs:
- 0014-2972
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.727100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3115.xml